A purple and pink letter v on a white background.
September 16, 2019

Teens and Aesthetic Medicine: 9 Guidelines to Consider

With the onset of selfie culture and the growing openness in discussions surrounding aesthetic treatments, it seems natural that we’re seeing a growing curiosity from prospective patients regarding medical aesthetic options at a younger age. But with Botox being recommended to patients are early as the time they hit their 20s  and celebrities more openly admitting to their cosmetic procedures, including one 17-year-old who was credited with a 70% increase in inquiries regarding lip filler in the U.K. alone, it seems inquiries from younger patients may be expected. Of course, the ethics surrounding aesthetic treatments for teens is an area that remains a little murky. That’s why we’ve rounded up a list of the top guidelines when considering treatments for prospective patients under the age of 18.

9 Guidelines to Consider Before Treating Young Patients

  1. Ensure a Guardian Is Present:  Depending on the area in which your clinic or medispa operates, there are different regulations regarding what treatments may be offered to patients under the age of 18. Regardless, it’s recommended that a legal guardian be present to offer consent and legally represent the patient’s wishes.

  2. Consider  Necessity:  It’s important to be frank with patients under 18 years old and their guardians. Elective procedures and treatments should be seriously considered, and all the associated risks need to be clearly understood.

  3. Fillers and Elective Surgery Are a “No”:  Teenage bodies are still developing. The patient’s appearance will continue to mature, meaning results from elective fillers, injectables, and invasive cosmetic surgery may alter as they mature and risk requiring a second procedure or touchup injections at best. Medical exceptions may be made but should be cautiously considered.

  4. Acne Treatments Are a “Yes”:  While a guardian should still be present to ensure the patient is fully aware of any potential risks and speak to contraindications, medical aesthetic treatments for acne reduction  may be considered a more acceptable treatment for some young patients struggling with chronic acne breakouts.

  5. Fat Reduction Treatments Can Wait:  While non-invasive body shaping treatments are a better option than invasive fat reduction procedures for patients in this age range, it’s still best to delay treatment for a couple years. According to most growth charts, females in particular gain a statistically significant amount of weight from 18 to 21 years of age, developing a curvier appearance. The resulting changes may alter their desire to seek surgical treatment or impact their level of satisfaction with the results.

  6. Psychological Screening:  Maturity may be a concern with younger patients as it can be difficult to gauge their influences and intentions for seeking treatment, alongside whether they fully comprehend any potential risks. The best way to determine whether a prospective teenage patient is mature enough to be considered a potential candidate for treatment is through the use of a psychological screening test.

  7. Consider Commitment: Opting into a treatment at a younger age may be a longer commitment to their new aesthetic. For example, lip injections were an in-demand treatment among young patients not all that long ago. However, this is the type of treatment that needs to be repeated with regular sessions in order to maintain appearance. As a result, younger patients should also be screened for their commitment to regular upkeep if that may be an intrinsic factor in the aesthetic treatment they’re considering.

  8. Repeat the Risks:  Teenagers, and the public in general, are acknowledged to often inflate the benefits and minimize risks, particularly when it comes to aesthetic treatments. While surgical options inevitably carry greater risk compared to their minimally invasive or non-invasive counterparts, it remains your duty as a treatment provider to ensure patients are properly screened and sign their consent and understanding prior to performing any treatment. As such, it’s recommended that you cover these bases and offer young patients a cooling off period to take home educational materials and seriously consider their choice prior to committing.

  9. Note the Costs:  While it might not be ideal to place a fine lens over pricing, younger patients often have limited disposable income and guardians may not be willing to spend too much to cover the treatment. As such, these patients may seek deals that help save on cost but may risk inadequate results, risking a negative online review or word of mouth. Pay attention to the cost conversation and know how to recognize a red flag  when you see it.

The Main Takeaway

Understanding regional regulations and establishing a guidebook for determining appropriate treatments for young patients ( which may include defining what may be too young) are two necessary steps to ensure you and your staff are treating these patients in a responsible manner. Suggesting high-quality skin care or non-invasive treatment alternatives may be a more conservative way to deliver the results these patients want with little to no downtime and built-in safety features to ensure patient comfort. Further, a comprehensive long-term treatment plan  may begin with preventative solutions and skin care essentials, working patients along to non-invasive and minimally invasive procedures once they mature. This is a safe and measured solution to ensure patient safety and optimal efficacy.

For versatility, consider Venus Versa™, a multi-treatment platform that offers some of the industry’s most in-demand aesthetic services—from acne reduction treatments to photorejuvenation, and IPL hair removal, among others—all in one easy-to-use workstation. Utilizing different applicators, physicians can customize a host of treatments to better serve a wider patient base. For those interested in learning more, contact an expert today using the contact button below.

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.